Income Statement (TTM)
ASEP Medical Holdings Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
|
|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 |
| Change (%) | 350.00 | 77.78 | 44.23 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | ||||
| Change (%) | ||||
| % of Revenue | ||||
| Gross Operating Profit | 0 | 0 | 0 | 0 |
| Change (%) | 350.00 | 77.78 | 44.23 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 5 | 4 | 4 | 3 |
| Change (%) | -4.47 | -6.41 | -23.03 | |
| % of Revenue | 22,039.66 | 4,678.71 | 2,463.00 | 1,314.40 |
| R&D | 1 | 0 | 0 | 0 |
| Change (%) | -30.58 | -35.22 | -61.98 | |
| % of Revenue | 3,209.76 | 495.17 | 180.45 | 47.57 |
| OpEx | 7 | 6 | 6 | 5 |
| Change (%) | -6.17 | -7.15 | -19.88 | |
| % of Revenue | 31,371.78 | 6,541.39 | 3,416.29 | 1,897.77 |
| Operating Income | -7 | -6 | -6 | -4 |
| Change (%) | -7.31 | -8.47 | -21.81 | |
| % of Revenue | -31,271.78 | -6,441.39 | -3,316.29 | -1,797.77 |
| Interest Expense | -0 | |||
| Change (%) | ||||
| % of Revenue | -1.28 | |||
| Net Income | -8 | -7 | -6 | -5 |
| Change (%) | -14.34 | -19.30 | -18.50 | |
| % of Revenue | -38,918.30 | -7,408.12 | -3,362.99 | -1,900.29 |
Source: Capital IQ
